Silverarc Capital Management’s Travere Therapeutics TVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-408,849	Closed	-$7.33M	–	78
2025 Q1	$7.33M	Buy	408,849 +131,484	+47%	+$2.36M	1.5%	20
2024 Q4	$4.83M	Buy	+277,365	New	+$4.83M	1.06%	32
2021 Q2	–	Sell	-20,000	Closed	-$499K	–	109
2021 Q1	$499K	Buy	+20,000	New	+$499K	0.27%	68